MARASTONI, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 6.377
EU - Europa 1.533
AS - Asia 953
SA - Sud America 9
AF - Africa 2
OC - Oceania 2
Totale 8.876
Nazione #
US - Stati Uniti d'America 6.373
CN - Cina 595
UA - Ucraina 492
TR - Turchia 330
DE - Germania 240
GB - Regno Unito 211
PL - Polonia 146
IT - Italia 109
SE - Svezia 107
FI - Finlandia 103
BE - Belgio 78
FR - Francia 27
VN - Vietnam 10
IR - Iran 9
IN - India 6
NL - Olanda 6
CL - Cile 5
RO - Romania 4
BR - Brasile 3
CA - Canada 2
DK - Danimarca 2
ES - Italia 2
MX - Messico 2
RU - Federazione Russa 2
ZA - Sudafrica 2
AT - Austria 1
AU - Australia 1
EE - Estonia 1
IS - Islanda 1
KG - Kirghizistan 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 8.876
Città #
Woodbridge 894
Fairfield 858
Houston 574
Jacksonville 556
Ann Arbor 492
Chandler 427
Ashburn 343
Seattle 325
Wilmington 305
Cambridge 246
Izmir 170
Nanjing 169
Warsaw 146
Dearborn 126
Beijing 106
Princeton 106
San Diego 103
Brussels 78
Boardman 73
Addison 67
Shenyang 48
Nanchang 43
Milan 41
Hebei 35
Ferrara 33
Jiaxing 28
Jinan 23
San Mateo 23
Tianjin 23
Auburn Hills 21
Bremen 19
Changsha 18
Kunming 18
London 16
Mountain View 16
Zhengzhou 15
Hefei 13
Falls Church 12
Norwalk 12
Ningbo 11
Dong Ket 10
Los Angeles 10
Des Moines 9
Indiana 9
Philadelphia 9
Redwood City 9
Guangzhou 8
Orange 8
Ardabil 7
Augusta 6
Verona 6
Lanzhou 5
Leawood 5
Haikou 4
Helsinki 4
New York 3
Redmond 3
Shanghai 3
Tappahannock 3
Bologna 2
Changchun 2
Chengdu 2
Florence 2
Fuzhou 2
Madrid 2
New Bedfont 2
Orpington 2
Phoenix 2
Qingdao 2
San Francisco 2
São Paulo 2
Walnut 2
Yellow Springs 2
Abbeville 1
Auckland 1
Baotou 1
Bari 1
Beirã 1
Bishkek 1
Bolton 1
Boulder 1
Cape Town 1
Caruaru 1
Chicago 1
Chiswick 1
Clearwater 1
Copenhagen 1
Delhi 1
Distrito Federal 1
Düsseldorf 1
Edinburgh 1
Ercolano 1
Frankfurt am Main 1
Garza García 1
Grassano 1
Hangzhou 1
Hanover 1
Islington 1
Kathmandu 1
Langfang 1
Totale 6.808
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 248
A CYCLIC PEPTIDE T ANALOGUE WITH HIGH CHEMOTACTIC ACTIVITY 145
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 135
C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors 129
Vinyl ester-based cyclic peptide proteasome inhibitors 127
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors 126
New class of proteasome 20S inhibitors: a crystallographic and molecular modelling study 123
Opioid agonists and antagonists. Peptides containing N-terminal allyl groups and/or a thiomethylene linkage in place of a peptide bond 120
Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors 119
Arecoline tripeptide inhibitors of proteasome 115
Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N-alkylglycine in place of residues in position 1, 3, 5 and 6 114
Synthesis and opioid activity of partial retro‐inverso analogs of dermorphin 114
P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors 109
Calmodulin Binding Sites of the Skeletal, Cardiac, and Brain Ryanodine Receptor Ca2+ Channels: Modulation by the Catalytic Subunit of cAMP-Dependent Protein Kinase? 109
Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells 109
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 108
null 107
Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: synthesis and immunological activity 107
Synthesis and Pharmacological Activity of Partially Modified Retro-Inverso Dermorphin Tetrapeptides 107
null 107
Structure-activity relationships of cyclic and linear peptide T analogues. 104
The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses 103
HIV-1 protease inhibitors containing an N-hydroxyamino acid core structure 103
Symmetry-based inhibitors of HIV-1 protease. Design, synthesis and preliminary structure-activity studies of acylated 2,3-diamino-1-hydroxypropanes and 2,4 diamino-1-hydroxybutanes 102
Peptidyl vinyl ester derivatives: New class of selective inhibitors of proteasome trypsin-like activity 101
Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues 100
A 500 MHz study of peptide T in a DMSO solution. 100
Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues 99
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors 99
Synthesis and biological activity of carboxyl terminally extended dermorphins. 99
α,β-Unsaturated N-Acylpyrrole Peptidyl Derivatives: New Proteasome Inhibitors 99
A Bioactive Fullerene Peptide 99
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 98
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 98
Conformational analysis of peptide T and of its C‐pentapeptide fragment 97
Synthesis and Opioid Activity of Dermorphin Tetrapeptides Bearing D-Methionine S-Oxide at Position 2 97
Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides 97
Amygdalin binds to the CD4 receptor as suggested from molecular modeling studies 97
null 96
Synthetic tetrapeptides related to dermorphin: Potent long lasting analgesic action following subcutaneous administration 96
Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors. 96
Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope 96
Trypanocidal activity of peptidyl vinyl ester derivatives selective for inhibition of mammalian proteasome trypsin-like activity 95
Synthesis and Opioid Activity of [sar4]dermorphin-Tetrapeptide Analogues 94
Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides 93
Reversed-phase HPLC study on the in vitro enzymic degradation of dermorphin. 93
Synthesis and activity of N-benzyl pseudopeptides HIV protease inhibitors 92
Peptide T-AraC Conjugates. Solid Phase Synthesis and Biological Activity of N4-(acylpeptidyl)-AraC 91
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes 91
Opioid peptides. Synthesis and binding properties of dermorphin related heptapeptides. 90
null 90
null 90
null 89
Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitors 88
null 87
Synthesis and activity of dermorphine growth hormone releasing factor hybrid peptides 86
Synthesis and binding of 3-aminopyridine derivatives at central nicotinic receptors 86
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 84
N-Terminal-prolonged vinyl ester-based peptides as selective proteasome b1 subunit inhibitors 83
In vivo measurement of ANP overall turnover and identification of its main metabolic pathways under steady state conditions in humans 82
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 82
Synthesis and structure activity relationships of delthorphine analogues 80
null 79
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TOWARDS LINEAR AND CYCLIC PEPTIDE T ANALOG 75
New cyclic peptide proteasome inhibitors 75
Opioid peptides. Biological study of (D-Meto2) dermorphin analogues in relation to the plurality of opioid receptors 74
Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues 74
Opioid peptides. Partially modified retro-inverso dermorphin analogues 74
Structure-activity relationships of HIV-1 protease inhibitors containing gem-diaminoserine core unit 72
null 72
Preparation of mono-radioiodinated tracers for study of the in vivo metabolism of atrial natriuretic peptide in humans 71
Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors 68
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 67
Effects of peptide T derivatives on the proliferation of cultured human keratinocytes. 64
New insights on μ/δ selectivity of opioid peptides: Conformational analysis of deltorphin analogues 64
null 62
Synthesis and activity of pseudotripeptide inhibitors of HIV-1 protease containing D(-)-O-(benzyl)tartaric acid. 62
Anodic mineralization of pentachlorophenol in alkaline media 62
Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit 62
Synthesis and biological activity of D-glucopyranosyl peptide T derivatives. 61
Symmetry-based HIV protease inhibitors containing (S,S) or (R,R) tartaric acid core structure. 59
Studies on the anti-phospholipase A2 and anti-inflammatory activities of a uteroglobin fragment and related peptides. 59
Synthesis and activity of new linear and cyclic peptide T derivatives. 57
Proteasome inhibitors: synthesis and activity of arecoline oxide tripeptide derivatives 57
Dehydro-dermorphins. II. Synthesis and biological activity of unsaturated dermorphin hexa and heptapeptides. 57
Peptide-based molecules for the production of positive charged liposomes and micelles 56
Synthesis and biological activity of chelator-peptide T conjugates 56
Conformational properties of deltorphin: new features of the delta-opioid receptors 56
Peptide-based cationic liposomes and micelles as a new tool for nonviral gene delivery 55
analisi volumetricaper precipitazione, chelometria ed ossidoriduzione 55
Structure-activity relationships of dermorphin tetrapeptides carrying a ketomethylene linkage. 54
New features of the δ opioid receptor: Conformational properties of deltorphin I analogues 54
Direct electro-oxidation of bisphenol-A in aqueous alkaline media 53
Dehydro-dermorphins. I. Influence of the stereo-orientation of aromatic groups in dermorphin-(1-5)-peptides to opioid activity. 53
Synthesis and antiaggregatory activity of antiflammin related peptides. 52
Structure-activity relationships of peptide T-related pentapeptides. 51
Studies on the anti-phospholipase A2 and anti-inflammatory activities of a synthetic nonapeptide from uteroglobin. 49
Synthesis and opioid activity of tyrosine sulfate containing dermorphin and deltorphin peptides 47
Opioid peptides. Synthesis and biological properties of dermorphin, related hexapeptides 47
null 46
Totale 8.731
Categoria #
all - tutte 22.353
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 287
Totale 22.640


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.336 0 0 9 45 15 14 151 10 110 232 276 474
2019/20202.287 375 71 75 315 161 297 288 237 175 200 55 38
2020/20211.317 121 110 59 172 46 143 50 155 26 180 186 69
2021/20221.257 44 91 76 89 108 43 55 74 46 80 86 465
2022/20231.039 119 40 30 121 176 163 50 94 137 14 54 41
2023/2024165 56 81 28 0 0 0 0 0 0 0 0 0
Totale 8.979